On Thursday, Aurobindo Pharma, a leading pharma company, signed an exclusive agreement with COVAXX, a US-based company for developing and commercialising COVID-19 vaccine i.e. UB-612, the first multitope peptide-based vaccine to fight COVID-19, for India and United Nations Children's Fund (UNICEF) agency.